Published in J Paediatr Child Health on November 01, 2005
Complete DNA sequences of two oka strain varicella-zoster virus genomes. J Virol (2008) 1.06
Epidemiological characteristics of varicella from 2000 to 2008 and the impact of nationwide immunization in Taiwan. BMC Infect Dis (2011) 0.86
Another vaccine, another step forward? J Paediatr Child Health (2005) 0.75
Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev (2007) 2.78
The association of respiratory viruses, temperature, and other climatic parameters with the incidence of invasive pneumococcal disease in Sydney, Australia. Clin Infect Dis (2005) 1.83
Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons. Neuroscience (2005) 1.76
Chemoprophylaxis for Haemophilus and meningococcal infections. Position paper, Royal Australasian College of Physicians. J Paediatr Child Health (1994) 1.70
Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening. Gut (1998) 1.68
Corticosteroids in acute bacterial meningitis. Cochrane Database Syst Rev (2003) 1.68
Lest we forget acute epiglottitis. J Paediatr Child Health (1998) 1.66
Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin. N Engl J Med (1974) 1.48
Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation. J Clin Oncol (2001) 1.47
Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. Cancer Treat Rep (1976) 1.45
Metastatic patterns of choroidal melanoma. Cancer (1974) 1.45
Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas. Am J Clin Oncol (1998) 1.45
Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas. J Clin Oncol (1999) 1.45
Health-related quality of life in patients with melanoma expressed as utilities and disability weights. Br J Dermatol (2014) 1.42
Potential impact of policy regulation and generic competition on sales of cholesterol lowering medication, antidepressants and acid blocking agents in Belgium. Acta Clin Belg (2012) 1.42
Variation in the precursor to the major merozoite surface antigens of Plasmodium falciparum. Mol Biochem Parasitol (1988) 1.41
Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40
Hib disease must be prevented. Med J Aust (1994) 1.39
The Wellcome Trust lecture. Genes for antigens of Plasmodium falciparum. Parasitology (1986) 1.39
Hepatitis A epidemiology in Australia: national seroprevalence and notifications. Med J Aust (2001) 1.38
High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence. J Clin Oncol (1997) 1.34
Beta-lactam antibiotics alone or in combination with gentamicin for therapy of gram-negative bacillary infections in neutropenic patients. Am J Med Sci (1976) 1.32
Precision top-quark mass measurement at CDF. Phys Rev Lett (2012) 1.30
Capsaicin sensitivity is associated with the expression of the vanilloid (capsaicin) receptor (VR1) mRNA in adult rat sensory ganglia. Neurosci Lett (1998) 1.29
Clotrimazole (Bay b 5097): in vitro and clinical pharmacological studies. Antimicrob Agents Chemother (1972) 1.28
Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G. Lancet (1974) 1.27
Review article: Oral, modified-release mesalazine formulations--proprietary versus generic. Aliment Pharmacol Ther (2003) 1.26
Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. Cancer Res (1974) 1.25
Differences in attitudes, beliefs and knowledge of hospital health care workers and community doctors to vaccination of older people. Vaccine (2008) 1.21
Sustained elevated levels of VCAM-1 in cultured fibroblast-like synoviocytes can be achieved by TNF-alpha in combination with either IL-4 or IL-13 through increased mRNA stability. Am J Pathol (1999) 1.21
Homoeopathic vaccination. What does it mean? Immunisation Interest Group of the Royal Alexandra Hospital for Children. Med J Aust (1994) 1.20
Prevention of neonatal group B streptococcal sepsis: is routine antenatal screening appropriate. Aust N Z J Obstet Gynaecol (1995) 1.18
Brasilian purpuric fever in central Australia. Lancet (1987) 1.17
National study of adverse reactions after vaccination with bacille Calmette-Guérin. Clin Infect Dis (2002) 1.16
The epidemiology of rubella and congenital rubella in Australia, 1992 to 1997. Commun Dis Intell (1999) 1.15
Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection. Epidemiol Infect (2007) 1.15
Extraskeletal myxoid chondrosarcoma. Long-term experience with chemotherapy. Am J Clin Oncol (1995) 1.15
Myxoid liposarcoma. Experience with chemotherapy. Cancer (1994) 1.13
Measurement of the WW + WZ production cross section using the lepton + jets final state at CDF II. Phys Rev Lett (2010) 1.12
First observation of the decay Bs0-->Ds-Ds+ and measurement of its branching ratio. Phys Rev Lett (2008) 1.11
Palliative care by family physicians in the 1990s. Resilience amid reform. Can Fam Physician (2001) 1.11
Hepatitis B prevention in Europe: a preliminary economic evaluation. Vaccine (1995) 1.10
The health and economic burden of chickenpox and herpes zoster in Belgium. Epidemiol Infect (2012) 1.09
Mutagenesis of the regulatory domain of rat protein kinase C-eta. A molecular basis for restricted histone kinase activity. J Biol Chem (1993) 1.08
Surgical management, DNA content, and patient survival in adrenal cortical carcinoma. Surgery (1995) 1.08
Evidence for a particle produced in association with weak bosons and decaying to a bottom-antibottom quark pair in higgs boson searches at the tevatron. Phys Rev Lett (2012) 1.08
Seventy-five years of estimating the force of infection from current status data. Epidemiol Infect (2009) 1.08
Measurement of sigma chi c2 B(chi c2-->J/psi gamma)/sigma chi c1 B(chi c1 -->J/psi gamma) in pp collisions at square root s=1.96 TeV. Phys Rev Lett (2007) 1.07
Precise measurement of the W-boson mass with the CDF II detector. Phys Rev Lett (2012) 1.06
Direct measurement of the W production charge asymmetry in pp collisions at square root s=1.96 TeV. Phys Rev Lett (2009) 1.04
Search for long-lived massive charged particles in 1.96 TeV pp collisions. Phys Rev Lett (2009) 1.03
Measurement of d sigma/dM and forward-backward charge asymmetry for high-mass Drell-Yan e(+)e(-) pairs from pp macro collisions at square root of s = 1.8 TeV. Phys Rev Lett (2001) 1.02
Pilot study of vitaxin--an angiogenesis inhibitor-in patients with advanced leiomyosarcomas. Cancer (2001) 1.01
Observation of Bs(0)-Bs(0) oscillations. Phys Rev Lett (2006) 1.00
Prolongation of postoperative disease-free interval and survival in human colorectal cancer by B.C.G. or B.C.G. plus 5-fluorouracil. Lancet (1976) 0.99
Impact of the Australian Measles Control Campaign on immunity to measles and rubella. Epidemiol Infect (2001) 0.98
Additional hospital stay and charges due to hospital-acquired infections in a neonatal intensive care unit. J Hosp Infect (2001) 0.97
Putative glycophorin-binding protein is secreted from schizonts of Plasmodium falciparum. Mol Biochem Parasitol (1987) 0.97
Chemotherapy in giardiasis: clinical responses and in vitro drug sensitivity of human isolates in axenic culture. J Pediatr (1986) 0.97
Adjuvant immunotherapy and chemoimmunotherapy in colorectal cancer of the Dukes' C classification. Preliminary clinical results. Cancer (1975) 0.97
Search for large extra dimensions in final states containing one photon or jet and large missing transverse energy produced in pp collisions at square root[s]=1.96 TeV. Phys Rev Lett (2008) 0.97
Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomas. J Clin Oncol (2000) 0.96
The Australian Measles Control Campaign, 1998. Bull World Health Organ (2001) 0.96
The natural history of resectable metastatic melanoma (Stage IVA melanoma). Cancer (1982) 0.96
The cost-effectiveness of varicella vaccine programs for Australia. Vaccine (1999) 0.96
Polarizations of J/psi and psi(2S) mesons produced in pp collisions at square root s = 1.96 TeV. Phys Rev Lett (2007) 0.96
Biochemical properties of rat protein kinase C-eta expressed in COS cells. FEBS Lett (1992) 0.96
Bone and joint infections caused by multiply resistant Staphylococcus aureus in a neonatal intensive care unit. Pediatr Infect Dis J (1992) 0.96
The primary structure of the imported mitochondrial protein, ornithine transcarbamylase from rat liver: mRNA levels during ontogeny. DNA (1985) 0.95
Measurement of the top-quark mass in all-hadronic decays in pp collisions at CDF II. Phys Rev Lett (2007) 0.95
Determinants of between-country differences in ambulatory antibiotic use and antibiotic resistance in Europe: a longitudinal observational study. J Antimicrob Chemother (2013) 0.95
Measurement of the strong coupling constant from inclusive jet production at the Tevatron pp collider. Phys Rev Lett (2002) 0.94
Bradyzide, a potent non-peptide B(2) bradykinin receptor antagonist with long-lasting oral activity in animal models of inflammatory hyperalgesia. Br J Pharmacol (2000) 0.94
Phase I study of tricyclic nucleoside phosphate using a five-day continuous infusion schedule. Cancer Res (1984) 0.94
Family Medicine residents' knowledge and attitudes about end-of-life care. J Palliat Care (2000) 0.94
Surgical strategy for the treatment of medullary thyroid carcinoma. Ann Surg (1999) 0.93
Search for gluinos and scalar quarks in pp collisions at square root[s] = 1.8 TeV using the missing energy plus multijets signature. Phys Rev Lett (2002) 0.93
Contact patterns and their implied basic reproductive numbers: an illustration for varicella-zoster virus. Epidemiol Infect (2008) 0.93
Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium. Epidemiol Infect (2010) 0.93
Health care incentives in immunisation. Aust N Z J Public Health (1999) 0.93
The seroepidemiology and transmission dynamics of varicella in Australia. Epidemiol Infect (2003) 0.92
Australia's notifiable diseases status, 1997. Annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell (1999) 0.92
Search for a fermiophobic Higgs boson decaying into diphotons in pp[over] collisions at sqrt[s] = 1.96 TeV. Phys Rev Lett (2009) 0.92
N-myc oncogene amplification in rhabdomyosarcoma at release. Lancet (1986) 0.92
Glial cell line derived neurotrophic factor (GDNF) regulates VR1 and substance P in cultured sensory neurons. Neuroreport (1999) 0.91
Abnormal spinal curvature and its relationship to pelvic organ prolapse. Am J Obstet Gynecol (2000) 0.91
Serial studies of immunocompetence of patients undergoing chemotherapy for acute leukemia. J Clin Invest (1974) 0.91
Induction of gene amplification by 5-aza-2'-deoxycytidine. Mutat Res (1992) 0.91
First measurement of the b-jet cross section in events with a W boson in pp collisions at square root(s) = 1.96 TeV. Phys Rev Lett (2010) 0.91
The cost of measles in industrialised countries. Vaccine (2003) 0.91
Immunisation coverage in Australian children: a systematic review 1990-1998. Commun Dis Intell (1999) 0.91
A highly basic N-terminal extension of the mitochondrial matrix enzyme ornithine transcarbamylase from rat liver. FEBS Lett (1984) 0.91
Occult pneumococcal bacteraemia and febrile convulsions. Br Med J (Clin Res Ed) (1983) 0.91
Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas. Cancer Treat Rep (1980) 0.90
Immunodiagnosis of acute leukemia: detection of residual disease. J Natl Cancer Inst (1974) 0.90
A short history of vaccination in Australia. Med J Aust (2001) 0.90
The emergence of resistant pneumococcal meningitis--implications for empiric therapy. Arch Dis Child (2002) 0.90
Search for Z' --> e+ e- using dielectron mass and angular distribution. Phys Rev Lett (2006) 0.90